Platypnea-Orthodeoxia Syndrome Associated with COVID-19 Pneumonia and Prolonged Treatment Due to Tamsulosin Use: A Case Report
Akademik Acil Tip Olgu Sunumlari Dergisi
; 14(1):7-9, 2023.
Article
in English
| EMBASE | ID: covidwho-20237999
ABSTRACT
Platypnea-orthodeoxia syndrome (POS) is an extremely rare condition. There are no other cases in the literature where tamsulosin has been reported to prolong POS treatment. A 67-year-old male patient was hospitalized due to COVID-19. He was followed up in the ward after being in the intensive care unit for ten days. There was a significant decrease in saturation (SaO2) when sitting and standing compared to lying. He was diagnosed with POS. However, there was no significant improvement in POS with exercises. After stopping the tamsulosin he was using, there was a dramatic improvement. He was discharged on the 72nd day of his hospitalization. Due to COVID-19, POS is more likely to appear than before. It is a condition that clinicians should recognize. The pathophysiology of POS has not been fully elucidated. The case we present suggests that alpha-blockers may also be related to pathophysiology.©Copyright 2020 by Emergency Physicians Association of Turkey -
covid-19; Platypnoea-orthodeoxia syndrome; SARS-CoV-2; aged; arterial oxygen saturation; article; case report; clinical article; coronavirus disease 2019; exercise; hospitalization; human; intensive care unit; male; nonhuman; physiotherapy; platypnea orthodeoxia syndrome; Severe acute respiratory syndrome coronavirus 2; sitting; alpha adrenergic receptor blocking agent; tamsulosin
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Case report
Language:
English
Journal:
Akademik Acil Tip Olgu Sunumlari Dergisi
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS